Main Article Content
Introduction: Allergic rhinitis is the most common allergic disease and has an increasing prevalence. Although corticosteroids are the major treatment option for allergic rhinitis, there is still no consensus on the type of corticosteroid used to improve symptoms. The aim of this study was to evaluate the effect of triamcinolone acetate on improving the symptoms and quality of life of patients with allergic rhinitis who underwent rhinoplasty.
Materials and Methods: In this randomized clinical trial, 100 patients were divided into two groups of 50. In the intervention group, 20 mg of triamcinolone was injected and the patients were monitored for one month, and the control group only underwent rhinoplasty. The results were analyzed using SPSS software version 22.
Results: The mean symptoms and quality of life after the intervention were significantly different between the two groups. The mean symptoms and quality of life of patients in the triamcinolone group were significantly different, before and after the intervention.
Discussion: The results showed that triamcinolone acetate injection in patients who underwent rhinoplasty had a greater effect on reducing symptoms and improving quality of life, in comparison with the control group who only underwent rhinoplasty.